LHC Group (LHCG) Azione Prezzo

LHC Group Inc is primarily active in the healthcare industry.

The main competitors of LHC Group Inc in the market include Amedisys Inc and Encompass Health Corporation.

LHC Group Inc has a rich history and background in the healthcare industry. Founded in 1994, the company has established itself as a leading provider of post-acute healthcare services across the United States. LHC Group offers a wide range of services, including home health, hospice, and community-based services, focused on improving patients' quality of life. With a dedicated team of healthcare professionals, LHC Group is committed to delivering personalized, high-quality care to its patients. Over the years, LHC Group has expanded its operations and earned a reputation for excellence in the industry. Today, it continues to grow and thrive, providing essential healthcare services to communities nationwide.

LHC Group Inc has achieved several significant milestones over the years. The company has experienced continuous growth and expansion, becoming a leading provider of post-acute healthcare services in the United States. LHC Group Inc has successfully completed numerous acquisitions, which have helped to enhance its geographic presence and service offerings. The company has also achieved strong financial performance, consistently delivering positive results and increasing shareholder value. Additionally, LHC Group Inc has gained recognition for its commitment to quality patient care, receiving accolades and certifications from reputable organizations. These accomplishments highlight LHC Group Inc's dedication to excellence and position it as a trusted leader in the healthcare industry.

LHC Group Inc is primarily present in the United States.

LHC Group Inc represents a strong set of values and corporate philosophy. This leading provider of in-home healthcare services is committed to delivering high-quality care with compassion and integrity. LHC Group focuses on patient-centered care, ensuring that individuals receive personalized treatment plans tailored to their specific needs. They prioritize innovation and continuous improvement while promoting a supportive and inclusive work environment for their team members. With a focus on professional growth and collaboration, LHC Group strives to enhance the quality of life for their patients, their families, and the communities they serve.

13 analisti valutano attualmente l’azione LHC Group: 0 raccomandano l’acquisto, 10 la tenuta e 3 la vendita.

LHC Group Prezzi Obiettivo Analisti 2026

Convertita al tasso di cambio attuale, l’azione LHC Group quota 152,36 EUR (169,81 USD).

L’azione LHC Group (LHCG) è quotata su 2 borse, tra cui: NASDAQ (LHCG), Frankfurt (LH6.F).

The LHC Group Inc is a leading company in home health care and offers a wide range of services tailored to the needs of each patient. The company was founded in 1994 and is headquartered in Lafayette, Louisiana. The LHC Group Inc is divided into three different business segments: Home Health, Hospice, and Community-Based Services. In the Home Health segment, the company offers a comprehensive range of services, including nursing, therapy, social work, dietary counseling, and home health supervision. The LHC Group's hospice services include palliative care, pain management, and emotional support during the end stages of illness. In addition, the company offers community-based services aimed at reducing the need for costly institutional care by providing care to patients in their home environment. These services include medical care, rehabilitation programs, and counseling services. One of the key strengths of the LHC Group is its focus on quality and efficiency in care. By working closely with physicians, hospitals, and other healthcare professionals, the LHC Group can ensure that their patients receive the best possible medical care while also ensuring patient safety and satisfaction. Additionally, the company has developed a comprehensive program to promote innovation and technology in order to ensure more efficient and effective healthcare delivery. To further expand the business, the LHC Group Inc invests in growth strategies such as acquisitions, partnerships, and joint ventures. For example, in 2019, the company acquired the domestic healthcare services of AtlantiCare Home Health and Hospice, a leading provider of home health services in New Jersey. Through this acquisition, LHC Group was able to expand its business in New Jersey and strengthen its presence in the region. In addition to the various services the company offers, the LHC Group Inc has also developed a wide range of products aimed at improving the quality of life and comfort of patients. These include portable medical devices such as ventilators, oxygen concentrators, and infusion pumps, as well as specialized medical equipment such as wheelchairs, walkers, and hospital beds. Overall, the LHC Group Inc has established itself as a leading company in home health care. With a continuous investment in quality, efficiency, and innovation, the company is well-positioned to continue to grow and meet the needs of patients in the United States and beyond.

Il fatturato non può essere attualmente calcolato per LHC Group.

Il profitto per LHC Group non può essere attualmente calcolato.

Il P/E per LHC Group non può essere attualmente calcolato.

L'indicatore Price-to-Sales (P/S) per LHC Group non può essere calcolato al momento.

Il Quality Score AlleAktien per LHC Group è 4/10.

L'ISIN di LHC Group è US50187A1079. L'ISIN (International Securities Identification Number) è un codice identificativo univoco a livello mondiale per i titoli.

Il WKN di LHC Group è A0EAST. Il WKN (Wertpapierkennnummer) è un codice identificativo tedesco a sei cifre per i titoli.

Il ticker di LHC Group è LHCG. Con questo simbolo di borsa vengono negoziate le azioni LHC Group in borsa.